To further characterize the anti-tumor activity of erlotinib and MLN0128, we performed apoptosis Caspase 3/7 assays measuring both early and late apoptosis in GBM192 and GBM218 PDXCs (Figure S3a,b). The gene discussed is CASP3; the disease is neoplasm.